Cognitive dysfunction in diabetes - the 'forgotten' diabetes complication: a narrative review

被引:0
作者
Sjoholm, Ake [1 ,2 ]
Bennet, Louise [3 ]
Nilsson, Peter M. [4 ]
机构
[1] Gavle Cent Hosp, Dept Internal Med, Div Endocrinol & Diabetol, SE-80324 Gavle, Sweden
[2] Univ Gavle, SE-80324 Gavle, Sweden
[3] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Clin Studies,Sweden Forum South, Lund, Sweden
[4] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Malmo, Sweden
关键词
Antidiabetic drugs; cognition; dementia; diabetes; epidemiology; BRAIN; IMPAIRMENT; DEMENTIA; STROKE;
D O I
10.1080/02813432.2025.2455136
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundIn addition to peripheral neuropathy of various kinds, diabetes can also cause central neuropathy, which among other things can manifest itself as premature cognitive dysfunction, often linked to vascular dysfunction. Although the link between diabetes and cognitive dysfunction was discovered more than 100 years ago and has important clinical implications, this diabetes complication remains relatively unknown. Recent years have seen research that has clarified cerebral insulin resistance and defective insulin signaling as examples of pathogenic factors behind this cognitive impairment in diabetes.MethodWe provide a narrative review of select and contemporary publications with relevance for the interface between diabetes/prediabetes and cognitive function.ResultsRecently published studies show that physical activity can reverse insulin resistance in the brain as well as cognitive impairment and pathological appetite regulation. Pharmacological interventions with, for example, nasal insulin, GLP-1 receptor agonists, SGLT-2 inhibitors, or PPAR-gamma agonists have also shown promising results.ConclusionOptimization of lifestyle factors (e.g. physical activity), as well as several pharmaceutical agents already in clinical use against diabetes, have shown promising results in improving cognitive function in diabetic patients. An important task for primary health care, where most patients with type 2 diabetes are diagnosed, treated, and followed, is to increase awareness and early detection of cognitive dysfunction in these patients for optimizing risk factor control.
引用
收藏
页码:448 / 454
页数:7
相关论文
共 61 条
[1]   A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol [J].
Barbera, Mariagnese ;
Lehtisalo, Jenni ;
Perera, Dinithi ;
Aspo, Malin ;
Cross, Mary ;
De Jager Loots, Celeste A. ;
Falaschetti, Emanuela ;
Friel, Naomi ;
Luchsinger, Jose A. ;
Gavelin, Hanna Malmberg ;
Peltonen, Markku ;
Price, Geraint ;
Neely, Anna Stigsdotter ;
Thunborg, Charlotta ;
Tuomilehto, Jaakko ;
Mangialasche, Francesca ;
Middleton, Lefkos ;
Ngandu, Tiia ;
Solomon, Alina ;
Kivipelto, Miia .
ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
[2]  
Bernard C, 1855, LECONS PHYSL EXPT AP, P296
[3]   Cognitive dysfunction in diabetes: how to implement emerging guidelines [J].
Biessels, Geert J. ;
Whitmer, Rachel A. .
DIABETOLOGIA, 2020, 63 (01) :3-9
[4]   Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study [J].
Biessels, Geert Jan ;
Verhagen, Chloe ;
Janssen, Jolien ;
van den Berg, Esther ;
Wallenstein, Gudrun ;
Zinman, Bernard ;
Espeland, Mark A. ;
Johansen, Odd Erik .
DIABETOLOGIA, 2021, 64 (06) :1235-1245
[5]   Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective [J].
Biessels, Geert Jan ;
Nobili, Flavio ;
Teunissen, Charlotte E. ;
Simo, Rafael ;
Scheltens, Philip .
LANCET NEUROLOGY, 2020, 19 (08) :699-710
[6]   Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial [J].
Biessels, Geert Jan ;
Verhagen, Chloe ;
Janssen, Jolien ;
van den Berg, Esther ;
Zinman, Bernard ;
Rosenstock, Julio ;
George, Jyothis T. ;
Passera, Anna ;
Schnaidt, Sven ;
Johansen, Odd Erik .
DIABETES CARE, 2019, 42 (10) :1930-1938
[7]   Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications [J].
Biessels, Geert Jan ;
Despa, Florin .
NATURE REVIEWS ENDOCRINOLOGY, 2018, 14 (10) :591-604
[8]  
Bjelland I., 2002, Journal of Psychosomatic Research, V52, P69, DOI [DOI 10.1016/S0022-3999(01)00296-3, 10.1016/s0022-3999, DOI 10.1016/S0022-3999]
[9]  
Chad Chew Eun Yip, 2023, Bioinformation, V19, P522, DOI 10.6026/97320630019522
[10]   Associations between depression and cognition, mild cognitive impairment and dementia in persons with diabetes mellitus: A systematic review and meta-analysis [J].
Chow, Yeng Yan ;
Verdonschot, Milou ;
McEvoy, Claire T. ;
Peeters, Geeske .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 185